| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,721 |
8,938 |
$85K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,874 |
2,948 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
429 |
315 |
$5K |
| 64493 |
|
458 |
243 |
$3K |
| 64635 |
|
177 |
101 |
$3K |
| 80305 |
|
2,932 |
1,846 |
$3K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
721 |
119 |
$2K |
| 64483 |
|
150 |
121 |
$1K |
| 64636 |
|
173 |
99 |
$1K |
| 64494 |
|
422 |
231 |
$799.45 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
121 |
99 |
$565.41 |
| 97032 |
|
567 |
95 |
$459.60 |
| 64484 |
|
99 |
76 |
$456.46 |
| 99490 |
Ccm add 20min |
440 |
319 |
$410.66 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
52 |
49 |
$250.56 |
| 99215 |
Prolong outpt/office vis |
16 |
15 |
$211.91 |
| 76881 |
|
21 |
12 |
$123.66 |
| 99439 |
|
180 |
121 |
$89.49 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,735 |
901 |
$23.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
187 |
138 |
$18.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
93 |
76 |
$9.58 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
26 |
15 |
$7.02 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
36 |
29 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13 |
12 |
$0.00 |
| 99406 |
|
14 |
12 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
26 |
13 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
26 |
13 |
$0.00 |